PLK2 and Parkinson disease: In a genetic PD rat model, PLK2 adeno-associated virus (AAV) overexpression of PLK2 reduced aSyn accumulation by 55.8% compared to kinase dead PLK2, resulting in reduced dopaminergic neurodegeneration and associated motor symptoms (Oueslati et al., 2013).